tiprankstipranks
Trending News
More News >
Kyntra Bio (KYNB)
NASDAQ:KYNB
US Market

Kyntra Bio (KYNB) Financial Statements

Compare
1,066 Followers

Kyntra Bio Financial Overview

Kyntra Bio's market cap is currently $31.88M. The company's EPS TTM is $49.61; its P/E ratio is 0.19; Kyntra Bio is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-3.89. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 29.62M$ 46.80M$ 140.73M$ 235.31M$ 176.32M
Gross Profit$ 14.06M$ 42.84M$ 120.45M$ -213.88M$ 167.45M
Operating Income$ -150.42M$ -322.72M$ -301.02M$ -288.53M$ -191.88M
EBITDA$ -142.43M$ -305.20M$ -282.82M$ -333.72M$ -164.28M
Net Income$ -47.58M$ -284.23M$ -293.65M$ -290.02M$ -189.29M
Balance Sheet
Cash & Short-Term Investments$ 50.48M$ 235.59M$ 422.01M$ 405.19M$ 686.54M
Total Assets$ 214.53M$ 423.53M$ 610.09M$ 773.82M$ 826.84M
Total Debt$ 90.17M$ 170.46M$ 89.89M$ 99.72M$ 39.76M
Net Debt$ 39.69M$ 56.77M$ -65.81M$ -71.50M$ -638.63M
Total Liabilities$ 398.16M$ 585.73M$ 611.57M$ 544.71M$ 385.39M
Stockholders' Equity$ -225.60M$ -204.17M$ -21.45M$ 209.15M$ 422.18M
Cash Flow
Free Cash Flow$ -138.26M$ -317.54M$ -184.67M$ -112.42M$ 77.61M
Operating Cash Flow$ -138.00M$ -315.02M$ -145.93M$ -82.23M$ 81.60M
Investing Cash Flow$ 125.99M$ 153.66M$ 89.12M$ -426.97M$ 452.49M
Financing Cash Flow$ -255.00K$ 122.75M$ 46.78M$ -563.00K$ 13.34M
Currency in USD

Kyntra Bio Earnings and Revenue History

Kyntra Bio Debt to Assets

Kyntra Bio Cash Flow

Kyntra Bio Forecast EPS vs Actual EPS